Who founded Excepgen?

Excepgen was founded by Thomas Folliard.

Who are Excepgen's investors?

Excepgen's investors include Oxonian Ventures, Pi Campus, Y Combinator, ZAKA VC.

Where is Excepgen headquartered?

Excepgen is headquartered in San Francisco, US.

Excepgen

YC W19

San Francisco, US · 3 employees · 4 known investors

Find your way into Excepgen

824 people in our graph share verified history with the Excepgen team — schools, employers, funds. One of them is your warm intro.

Erin Price-Wrightunlockedknows Thomas Folliard · together at University of Oxford (overlapped)

×8knows the team · via Y Combinator

knows the team · via University of Oxford

knows the team · via UCL

knows the team · via University of Southampton

ExcepGen develops biologics, gene therapies, and vaccines using synthetic biology approaches to create therapies that operate outside normal cellular regulation constraints.

Also known as Excepgen INC

AI & Machine Learning Biotech HealthtechUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W19)

Thomas Folliard inFounderThomas Folliard founded ExcepGen, which develops biologics, gene therapies, and vaccines using synthetic biology. He has expertise in foundational engineering of biology and drug discovery.

Investors · 4

Oxonian VenturesPalo Alto

Pi CampusRome · $55K – $540K

Y CombinatorSan Francisco · $500K

ZAKA VCSan Francisco

Competitors · 3

by search overlap

Biogen Idec5 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.

Macrogenics Inc5 shared keywordsMacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.

PepGen3 shared keywordsPepGen is a clinical-stage biotech company developing oligonucleotide therapies for neuromuscular and neurological diseases using its Enhanced Delivery Oligonucleotide (EDO) platform to improve tissue penetration and uptake in muscle tissues.

Companies competing with Excepgen for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Excepgen do?: ExcepGen develops biologics, gene therapies, and vaccines using synthetic biology approaches to create therapies that operate outside normal cellular regulation constraints.
Who founded Excepgen?: Excepgen was founded by Thomas Folliard.
Who are Excepgen's investors?: Excepgen's investors include Oxonian Ventures, Pi Campus, Y Combinator, ZAKA VC.
Where is Excepgen headquartered?: Excepgen is headquartered in San Francisco, US.